Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Press Release

    Press Release

    Health Insurance- The Best Backup Plan in Today

    Health Insurance- The Best Backup Plan in Today's Times

    Medical Dialogues Bureau13 Nov 2019 11:44 AM IST
    Healthcare delivery sector is advancing at a lightening pace with doctors now capable to threatening many threatening diseases that earlier were...
    Syngene reports robust 11% YOY revenue growth in Q2 FY20

    Syngene reports robust 11% YOY revenue growth in Q2 FY20

    Medical Dialogues Bureau23 Oct 2019 12:18 PM IST
    Bengaluru: Syngene International Limited recently announced its Q2 FY20 results posting quarterly revenue of Rs. 485 Cr, an increase of 11% from the...
    Harmony Biosciences Announces FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy

    Harmony Biosciences Announces FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy

    Medical Dialogues Bureau19 Aug 2019 3:43 PM IST
    Harmony Biosciences, LLC (Harmony) announced that the U.S. Food and Drug Administration (FDA) approved WAKIX (pitolisant) for the treatment of...
    HCL Technologies and Oracle Health Sciences Collaborate to Accelerate MHealth in Clinical Trials

    HCL Technologies and Oracle Health Sciences Collaborate to Accelerate MHealth in Clinical Trials

    Medical Dialogues Bureau6 Aug 2019 4:37 PM IST
    HCL Technologies (HCL), a leading global technology company and a Platinum-Level member of Oracle Partner Network (OPN), and Oracle Health Sciences...
    USFDA completes inspection at Laurus Labs

    USFDA completes inspection at Laurus Labs' AP unit

    Medical Dialogues Bureau19 July 2019 10:02 AM IST
    Mumbai: Laurus labs recently announced that they have completed the US Food and Drug Administration (USFDA) inspection of Unit 4 at Visakhapatnam,...
    Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH

    Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH

    Medical Dialogues Bureau19 Jun 2019 12:01 PM IST
    AHMEDABAD: Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has completed enrolment of 104 patients with...
    USFDA permits marketing of first medical device for treatment of ADHD

    USFDA permits marketing of first medical device for treatment of ADHD

    Medical Dialogues Bureau21 April 2019 10:26 AM IST
    The U.S. Food and Drug Administration permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD). The...
    USFDA nod to Teva generic nasal spray-Narcan to treat opioid overdose

    USFDA nod to Teva generic nasal spray-Narcan to treat opioid overdose

    Medical Dialogues Bureau21 April 2019 9:27 AM IST
    The U.S. Food and Drug Administration granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a...
    Desi AI based healthtech startup NIRAMAI raises Rs 42.6 Crore in Series A Funding

    Desi AI based healthtech startup NIRAMAI raises Rs 42.6 Crore in Series A Funding

    Garima25 Feb 2019 4:04 PM IST
    Bengaluru: Artificial intelligence based health tech startup NIRAMAI Health Analytics, has announced that it has closed $6 mn in a Series A round of...
    Hetero Labs Limited acquires Tarbis Farma in Spain

    Hetero Labs Limited acquires Tarbis Farma in Spain

    Medical Dialogues Bureau3 Jan 2019 9:15 AM IST
    The acquisition enables Hetero with a strong front-end marketing presence giving Amarox the required commercial infrastructure, product portfolio,...
    SCHOTT KAISHA launches customizable prefillable glass syringes in India

    SCHOTT KAISHA launches customizable prefillable glass syringes in India

    Medical Dialogues Bureau1 Jan 2019 9:30 AM IST
    Rishad Dadachanji, Director, SCHOTT KAISHA shares, "The syriQ BioPure syringes, manufactured in St. Gallen, Switzerland, combine features to ensure...
    True Properties of Vitamin E Overlooked: Merck Launches Book for Awareness

    True Properties of Vitamin E Overlooked: Merck Launches Book for Awareness

    Medical Dialogues Bureau21 Oct 2018 12:01 PM IST
    Mumbai: Merck Consumer Health India - a leader in Vitamin E in India - announced the publication of the country’s first handbook that highlights the...
    Next

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    MSD India appoints Rehan A Khan as Managing Director

    MSD India appoints Rehan A Khan as Managing Director

    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Government appoints 108 drug inspectors pan India; Details

    Government appoints 108 drug inspectors pan India; Details

    Alkem Labs Founder Samprada Singh passes away at the age of 92 years

    Alkem Labs Founder Samprada Singh passes away at the age of 92 years

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok